We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT)

This study is currently recruiting participants.
Verified October 2016 by Sebastian Wolf, University Hospital Inselspital, Berne
Sponsor:
ClinicalTrials.gov Identifier:
NCT00564291
First Posted: November 27, 2007
Last Update Posted: October 25, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
University of Bern
Information provided by (Responsible Party):
Sebastian Wolf, University Hospital Inselspital, Berne
  Purpose
Comparison of different OCT instruments to assess retinal thickness, correlation to fluorescein angiography, and visual outcome after therapy with anti-VEGF therapy

Condition Intervention
Macular Edema CNV Other: Examination with an OCT device

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Evaluation of Retinal Structure With High Resolution OCT

Further study details as provided by Sebastian Wolf, University Hospital Inselspital, Berne:

Primary Outcome Measures:
  • Integrity of retinal layers [ Time Frame: End of study ]

Estimated Enrollment: 700
Study Start Date: January 2007
Estimated Study Completion Date: November 2017
Estimated Primary Completion Date: November 2017 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
Healthy volunteers
Other: Examination with an OCT device
2
CSME secondary to diabetic retinopathy
3
ARMD with CNV before and after therapy
Other: Examination with an OCT device
4
ARMD atrophic
Other: Examination with an OCT device
5
Retinal vein occlusion
Other: Examination with an OCT device
6
retinitis pigmentosa
Other: Examination with an OCT device
7
vitreoretinal proliferation
Other: Examination with an OCT device

Detailed Description:
Comparison of different OCT instruments to assess retinal thickness, correlation to fluorescein angiography, and visual outcome after therapy with anti-VEGF therapy
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 100 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
healthy subjects and patients with macular diseases
Criteria

Inclusion Criteria:

  • Macular disease
  • Healthy subjects
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00564291


Contacts
Contact: Sebastian Wolf, MD, PhD sebastian.wolf@insel.ch

Locations
Switzerland
Dep. Ophthalmology, University Hospital Bern Recruiting
Bern, Switzerland, 3010
Contact: Sebastian Wolf, MD PhD       sebastian.wolf@insel.ch   
Sub-Investigator: Martin Zinkernagel, MD PhD         
Sub-Investigator: Andreas Ebneter, MD         
Sub-Investigator: Marion Munk, MD         
Klinik und Poliklinik für Augenheilkunde, University Bern Recruiting
Bern, Switzerland
Principal Investigator: Ute Wolf-Schnurrbusch, MD         
Sponsors and Collaborators
Sebastian Wolf
University of Bern
Investigators
Principal Investigator: Sebastian Wolf, MD, PhD University of Bern
Study Director: Sebastian Wolf, MD PhD University of Bern
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Sebastian Wolf, Director, University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier: NCT00564291     History of Changes
Other Study ID Numbers: KEK 044/07
First Submitted: November 26, 2007
First Posted: November 27, 2007
Last Update Posted: October 25, 2016
Last Verified: October 2016

Keywords provided by Sebastian Wolf, University Hospital Inselspital, Berne:
OCT

Additional relevant MeSH terms:
Macular Edema
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases